antipsychotic Flashcards
neuroleptic drugs
do not cure underlying dz- help pt funx more effectively
classified as typical(1st gen) or atypical(2 gen)
main MOA- blockade of dopamine receptors in brain- both classifications affect various receptor subtypes of NE, acetylcholine, & histamine
atypical also serve as antagonists or partial antagonists to serotonin receptors
neuroleptic drug receptors blockade
- 5 dopamine receptors identified, blockade of D2 receptors
- psychotic experiences have been related to excessive dopamine in the mesolimbic pathway
- non-specific blockade of dopamine in other pathways is what is thought to cause unfavorable SE in the drugs
adverse effects of neuroleptic drugs
- tremors/parkinsonian effects- dystonia, extrapyramidal signs
- tardive dyskinesia- facial grimacing, involuntary movements that may appear & continue after drug is ceased
- blurred vision, dry mouth, constipation, urinary retention
- inc prolactin release
- postural hypotension
- sexual dysfunction
- drowsiness
- anti emetic effects are common- tx for nausea of chemotherapy
neuroleptic malignant syndrome
rare SE from neuroleptic drugs
catatonia, fluctuating blood pressure, dysarthria, fever
may be fatal if drug is not discontinued immediately & pt receives tx with a DOPAMINE AGONIST(BROMOCRIPTINE)
chlorpromazine/ thorazine
typical neuroleptic
for psychosis, mania, schizophrenia, N/V & **intractable hiccoughs
MOA- chiefly D2 dopaminergic receptor site blockade. also alpha-adrenergic blockade & H1 blockade(anti-histamine effects)
SE- INC release of PROLACTIN- glalctorrhea & amenorrhea in women, infertility in both sexes. same SE as previously mentioned(parkinsonian sxs)
prochlorperazine/ compazine
typical neuroleptic
for psychosis, vertigo, N/V- particularly assoc. w/migraine
MOA- H1-histamine receptor antagonist, alpha-adrenergic receptor antagonist, D2 dopaminergic receptor antagonist
-better anitemetic effect than other neuroleptics
-less orthostatic hypotension & extrapyramidal signs than chlorpromazine
SE- drowsiness, dry mouth, constipation, urinary retention. lowers seizure threshold. extrapyramidal signs usu only w/high doses for long periods
haloperidol/ haldol
typical neuroleptic
for psychosis, tourette’s, huntington’s dz, ACUTE AGITATED BEHAVIOR
MOA- chiefly D2 doapminergic receptor site blockade. less muscarinic & alpha-adrenegric receptor blockade as compared to other neuroleptics
-careful admin to prevent excessive sedation & tarditive dyskinesia
SE- parkinsonian-like sxs, EXTRAPYRAMIDAL effects(m/b dramatic), NEUROLEPTIC MALIGNANT SYNDROME is a sig. possibility
clozapine/ clozaril
atypical neuroleptic(1st developed)
for schizophrania- esp when other anti-psychotics have failed or produced undesirable effects
MOA- multiple receptor site blockade- mostly on D2 & 5-HT2(serotonin) receptor sites
PO- rapid absorption & extensive metabolism
SE- less extrapyramidal than other drugs. AGRANULOCYTOSIS in 1-2% of pts, MYOCARDITIS, s/t severe weight gain
respiradone/ risperdal
atypical neuroleptic
for psychosis
MOA- presumed dopamine & serotonin receptor blockade
SE- extrapyramidal sx, tarditive dyskinesia, constipation, sedation.WEIGHT GAIN< HYPERGLYCEMIA & DM. inc risk of STROKE in older pts.
slow withdrawl recomended to red. risk of acute psychosis
olanzaprine/ zyprexa
atypical neuroleptic
for schizophrenia when other drugs have failed
MOA- multiple receptor site blockade, esp. D2 & 5-HT2 receptor sites
PO, rapid absorption & extensive metabolism
SE- relativly diminished extrapyramidal SE compared to other neuroleptics. WT GAIN, HYPERGLYCEMIA< DM. inc risk for STROKE in elderly
lithium salts
prophylactic tx of bipolar DO, and tx of manic episodes
MOA- exact MOA unknown- widely distributed in CNS, interacts with many neurotransmitters & receptors- dec NE release & inc serotonin synthesis. diminishes CNS response to glutamate
lithium carbonate/ eskalith
lithium salt
for bipolar DO & manic episodes, schizophrenia
MOA- previous slide
char- cleared by kidneys, narrow TI- must check blood levels frequently!! sxs of high blood lvls- lethargy, confusion, diarrhea, abd pn, N/V, ataxia, severe tremors. seizures can develop as well cardiotoxicity
SE- wt gain, cognitive impairment, short term memory deficits- lack of compliance
reduced renal response to ADH= impaired urine concentration capacity
**nephrogenic diabetes insipidus= polyuria in 20% of pts on chronic tx
**hypothyroidism 5-35% of pts on long term therapy